NEW INSIGHTS INTO GASTRO-RETENTIVE FLOATING DRUG DELIVERY SYSTEMS
Manisha Ware*, Sandip Prasad Tiwari, Amit Roy, Trilochan Satapathy
ABSTRACT
In recent year, considerable attention has been focused on the
formulation and development of new drug for orally targeted drug
delivery systems. The oral route is most popular route of drug
administration. Conventional dosage forms are unable to control either
the rate or site of action. When a drug is delivered as a conventional
dosage form they show very short gastric retention time. As such the
drug which act locally in the stomach or get degraded by the colonic
bacteria or/ and alkaline pH of the small intestine cannot be formulate
as conventional dosage form. In conventional dosage forms,
fluctuating drug level may lead to some side effect and dosing interval
is short, this leads to poor patient compliance. At present a number of
approaches are utilized in the prolongation of the GRT, including
floating drug delivery systems (FDDS), swelling and expanding system, mucoadhesive
system, high density system, modified system and other delayed gastric emptying systems.
Floating drug delivery systems has density lower than gastric fluid, so that it has tendency to
float over gastric contents and remain in the stomach for prolonged period of time. The
hydrodynamically balanced gastrointestinal drug delivery system is designed to prolong the
GI residence in area of the GI tract to maximize the absorption of drug at the desired site in
the solution form and hence increase the absorption.
Keywords: Gastric retention, FDDS, High density system, Mucoadhesive system.
[Download Article]
[Download Certifiate]